MSTN and metabolic dysfunction-associated steatotic liver disease: Obesity and NAFLD, as closely related conditions, share many potential mechanisms that could worsen sarcopenia, including increased inflammation [6], hormonal derangements [2], altered myokines secreted by skeletal muscle (myostatin, adiponectin) [7,8], physical inactivity [9], and insulin resistance [10].